understanding-pk-distribution-by-quantitative-mass-spectrometry-qmsi-and-lc-ms-ms

Understanding PK distribution by Quantitative Mass Spectrometry (QMSI) and LC-MS/MS

In traditional approaches to pharmacokinetic analysis of drug candidates using LC-MS/MS the spatial information is not typically retained. With more targeted therapies to specific cells and tissues, understanding the drug exposure to the targets becomes a very important information in the first step of in vivo animal and human trials.

With the technology harnessed at ImaBiotech, it is possible to directly quantify the biodistribution of drugs and biomarkers at the earliest stages of in vivo testing. Using our innovative services, you can easily evaluate drug pharmacokinetics and pharmacodynamics at the tissue level and quantify the biological target exposure at the site of action. In this webinar, we will discuss how the combination of traditional LC-MS/MS and QMSI can support your drug development program. 

Conference animated by :

Corinne Ramos

Corinne Ramos

Director Innovation & Marketing,

ImaBiotech

Erika Pfaunmiller

Erika Pfaunmiller

Director Business Development,

ImaBiotech

Wednesday, February 24th 2021

from 16:30 to 17:30

(Europe/Paris)

179 subscribers | 60 mins

Subscription 100% free

Email notifications before the webinar

Chat zone to ask your questions

Replay until April 2, 2021